Source: Bju international. Unidade: FM
Subjects: CÁLCULOS URINÁRIOS, RESULTADO DE TRATAMENTO, ESTUDOS RANDOMIZADOS, PLACEBO
ABNT
BATAGELLO, Carlos A et al. Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double-blinded, placebo-controlled trial. Bju international, v. 129, n. 1, p. 35-47, 2022Tradução . . Disponível em: https://doi.org/10.1111/bju.15378. Acesso em: 15 nov. 2024.APA
Batagello, C. A., Vicentini, F. C., Monga, M., Miller, A. W., Marchini, G. S., Torricelli, F. C. M., et al. (2022). Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double-blinded, placebo-controlled trial. Bju international, 129( 1), 35-47. doi:10.1111/bju.15378NLM
Batagello CA, Vicentini FC, Monga M, Miller AW, Marchini GS, Torricelli FCM, Danilovic A, Coelho RF, Srougi M, Nahas WC. Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double-blinded, placebo-controlled trial [Internet]. Bju international. 2022 ; 129( 1): 35-47.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/bju.15378Vancouver
Batagello CA, Vicentini FC, Monga M, Miller AW, Marchini GS, Torricelli FCM, Danilovic A, Coelho RF, Srougi M, Nahas WC. Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double-blinded, placebo-controlled trial [Internet]. Bju international. 2022 ; 129( 1): 35-47.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/bju.15378